A PI3Kd-Foxo1-FasL signaling amplification loop rewires CD4+ T helper cell signaling, differentiation and epigenetic remodeling 4854
Abstract Description While inputs regulating CD4+ T helper cell (Th) differentiation are well-defined, the integration of downstream signaling with transcriptional and epigenetic programs that define Th-lineage identity remain unresolved. PI3K signaling is a critical regulator of T cell function; activated PI3Kδ syndrome (APDS) is an inborn error of immunity caused by heterozygous activating mutations in PI3Kδ. APDS patients have recurrent respiratory infections (Th1-type) and develop allergic (Th2-type) diseases; we therefore hypothesized that activated-PI3Kδ (Pik3cdE1020K) signaling may alter CD4 T cell differentiation. Using mice expressing activated-PI3Kδ, we found aberrant expression of proinflammatory Th1-signature genes under Th2-inducing conditions, following both house dust mite induced asthma in vivo and CD4 T cell polarization in vitro. This dysregulation was driven by a robust PI3Kδ-IL-2-Foxo1 signaling loop, fueling Foxo1-inactivation, loss of Th2-lineage restriction, altered chromatin accessibility and global impairment of CTCF-DNA interactions. Surprisingly, ablation of Fasl, a Foxo1-repressed gene, restored normal Th2 differentiation, TCR signaling and CTCF expression. BioID proximity labeling revealed Fas interactions with TCR-signaling components, which were supported by Fas-mediated potentiation of TCR signaling. Our results highlight Fas-FasL signaling as a critical intermediate in phenotypes driven by activated-PI3Kδ, thereby linking two key pathways of immune dysregulation. Funding Sources This work was supported by the Division of Intramural Research of NIAID, NIH. Topic Categories Lymphocyte Differentiation and Peripheral Maintenance (LYM)
Authors
- Pamela L Schwartzberg (ORCID: https://orcid.org/0000-0002-0817-3657)
- Hiroyuki Nagashima (ORCID: https://orcid.org/0000-0001-8405-6746)
- Kirk M. Druey (ORCID: https://orcid.org/0000-0002-5834-6501)
- Nicolás Pereira (ORCID: https://orcid.org/0000-0002-8859-8005)
- Dominic P. Golec (ORCID: https://orcid.org/0000-0002-2741-3302)
- Yu Kang (ORCID: https://orcid.org/0000-0003-1197-4727)
- Jillian Perry
- Alejandro V. Villarino (ORCID: https://orcid.org/0000-0001-8068-2176)
- Behdad Afzali (ORCID: https://orcid.org/0000-0003-2968-1156)
- Pedro Henrique Gazzinelli-Guimarães (ORCID: https://orcid.org/0000-0003-4932-2206)
- Justin Lack (ORCID: https://orcid.org/0000-0003-0584-4010)
- Anthony Cruz
- Fabrício Marcus Silva Oliveira (ORCID: https://orcid.org/0000-0001-9963-1758)
- John J. O’Shea (ORCID: https://orcid.org/0000-0002-6456-9752)
- Thomas B. Nutman (ORCID: https://orcid.org/0000-0001-6887-4941)
- Jennifer L. Cannons
- Daniel Chauss (ORCID: https://orcid.org/0000-0002-8343-0860)
- Tom Hill
- Ilin Joshi
Institutions
- University of Miami (US)
- Georgetown University (US)
- George Washington University (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- National Institute of Allergy and Infectious Diseases (US)
Publication Details
- Journal
- The Journal of Immunology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1093/jimmun/vkaf283.2464
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- National Institute of Arthritis and Musculoskeletal and Skin Diseases